Posted on 11/26/20
| News Source: i24
UK-Swedish pharmaceutical giant AstraZeneca and the Oxford University acknowledged Wednesday a mistake in the trials of their vaccine against COVID-19 coronavirus, which make have impacted the interim results reported earlier.
In a previous statement, the researchers said it showed a 90-percent effectivity when administered in a specific dosage — half a dose first, and then a full dose after a gap.
Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more
Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens
Among those who had both inoculation shots administer full doses, the effectivity was only 62 percent, however.
In a statement on Wednesday, Oxford said that the concentration of the vaccine used for some of the shots was below the necessary level due to an error.
Read more at i24NEWS.